Smart Inhalers - Global Market Outlook (2016-2022) - Research and Markets

DUBLIN--()--The "Smart Inhalers - Global Market Outlook (2016-2022)" report has been added to Research and Markets' offering.

The Global Smart Inhalers market is expected to reach $198 million growing at a CAGR of 65.5% from 2015 to 2022. Increasing respiratory disorders, rise in air pollution, improved adherence to the inhaler are some of the factors boosting the market growth.

However, lesser availability of smart inhalers, high expenditure of asthma and COPD treatment, and resistance towards adoption of smart inhalers are hindering the market growth.

North America is projected to be the leading revenue generating region, whereas Asia-Pacific is projected to grow at the highest rate, due to rise in demand for smart inhalers and increase in COPD and asthma instances.

Products Covered:

  • Inhalers
  • Nebulizers
  • Smater Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)

Disorders Covered:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

End Users Covered:

  • Patients
  • Research & Development

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Smart Inhalers Market, By Product

6 Global Smart Inhalers Market, By Disorder

7 Global Smart Inhalers Market, By End User

8 Global Smart Inhalers Market, By Geography

9 Key Developments

10 Company Profiling

  • 3M Drug Delivery Systems
  • Adherium Limited
  • AstraZeneca plc
  • Boehringer Ingelheim GmbH
  • CoheroHealth
  • Crux Product Design Ltd
  • e-pill, LLC
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals
  • Inspiro Medical Ltd
  • Novartis AG
  • Novartis AG
  • OMRON Healthcare Europe B.V
  • Opko Health
  • PARI GmbH
  • Philips Respironics
  • Propeller Health
  • Qualcomm Life
  • Sensirion AG
  • Shenzhen Bi-Rich Medical Devices Co., Ltd
  • Teva Pharmaceutical Industries Ltd.
  • TRI-MED, INC.
  • Vectura Group plc

For more information about this report visit https://www.researchandmarkets.com/research/xhmhwj/smart_inhalers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Inhalers and Nebulisers, Respiratory Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Inhalers and Nebulisers, Respiratory Devices